NExTNet vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionNExTNetIsomorphic Labs
PricingFreemiumContact for pricing
Target AudienceResearchers & biotech professionalsPharma companies & large drug development programs
Core OfferingAI-powered research platform with connected knowledge mapsAI-driven drug design engine for pharma partnerships
Technology BaseSemantic web & AI CopilotAlphaFold & proprietary predictive/generative models
Key IntegrationsChEMBL, PubMed, Ensembl, Google ScholarNot specified (pharma partnerships instead)
Latest News2026-06-17: NetNewsWire RSS discussion (unrelated)2026-05-12: Series B funding; Jan 2026: J&J collaboration

If you are an individual researcher or small team needing a ready-to-use tool for literature mining and hypothesis generation, NExTNet's freemium model and integrated semantic search are ideal. For pharma companies pursuing large-scale drug development through deep AI partnerships, Isomorphic Labs' AlphaFold-powered engine and recent Series B funding reflect proven enterprise capability, albeit with high upfront commitment.

NExTNet
NExTNet

Evidence-backed AI copilot with connected knowledge maps for life sciences research.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Freemium
Contact Sales
Plans
$0/mo
$20/mo (annual) or $25/mo (monthly)
$50/mo (annual) or $62.50/mo (monthly)
$200/mo (annual) or $250/mo (monthly)
Custom
Popularity
2 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
Categories
🔬 Research & Education🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Evidence-backed AI Copilot with citations
Connected Search Engine (Explorer) with interactive maps
Semantic web unifying ChEMBL, PubMed, Ensembl, Google Scholar
Interactive maps for genes, drugs, targets, pathways, diseases
List view for browsing biomedical entity details
Copilot voice mode for hands-free interaction
Copilot advanced reasoning mode for deeper analysis
AI podcast generation from research content
File uploads for document analysis
Reader for open-access articles
Shareable team spaces and collections
Chat and search session history retention (14-365 days)
Multi-plan quotas: responses, sources, and searches per month
Bring-your-own data integrations (Starter and above)
Nextnet Notebooks for research notes (Coming Soon)
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts
Integrations
ChEMBL
PubMed
Google Scholar
Ensembl

What real users say: NExTNet vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

NExTNet

21 mentions across 4 sources · 51% positive — mixed

YouTube, Product Hunt, Bluesky, GitHub

What users praise

  • Easy to get started with a free plan.
  • Visual knowledge graphs for exploring life sciences topics.
  • Integrates data from ChEMBL, PubMed, Ensembl, Google Scholar.
  • Designed specifically for life science researchers.

What frustrates them

  • Almost no real user feedback to validate claims.
  • Product Hunt launch received zero upvotes.
  • Brand confusion with other 'nextnet' projects.
  • Free plan has limited usage and features.

Researched Jul 5, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Academic researcher investigating gene-disease links
    Pick: NExTNet

    NExTNet's freemium access and integration with PubMed, Ensembl, and Google Scholar allow for cost-effective literature mining and connection mapping.

  • Pharma company targeting a novel protein for drug design
    Pick: Isomorphic Labs

    Isomorphic Labs' AlphaFold-based Drug Design Engine and partnership model are tailored for large-scale predictive modeling and lead optimization.

  • Biotech startup needing collaborative discovery
    Pick: NExTNet

    NExTNet's sharing and collaboration features, plus its affordable pricing, suit small teams exploring early drug targets.

  • Large pharma organization seeking digital biology at scale
    Pick: Isomorphic Labs

    Isomorphic's Series B funding and J&J collaboration validate its capability for multi-billion-dollar pipeline acceleration.

Frequently Asked Questions

NExTNet vs Isomorphic Labs: which should you choose?

If you are an individual researcher or small team needing a ready-to-use tool for literature mining and hypothesis generation, NExTNet's freemium model and integrated semantic search are ideal. For pharma companies pursuing large-scale drug development through deep AI partnerships, Isomorphic Labs' AlphaFold-powered engine and recent Series B funding reflect proven enterprise capability, albeit with high upfront commitment.

Can I use Isomorphic Labs as an individual researcher?

No, Isomorphic Labs only partners with pharma companies and large drug development programs; individuals should use NExTNet.

Does NExTNet integrate with drug databases like ChEMBL?

Yes, NExTNet integrates ChEMBL, PubMed, Ensembl, and Google Scholar for evidence-backed answers.

Is Isomorphic Labs based on AlphaFold?

Yes, it builds on the Nobel Prize-winning AlphaFold system for protein structure prediction.

What is the pricing for NExTNet?

Freemium; basic features free, Pro Plus for unlimited usage.

Has Isomorphic Labs raised recent funding?

Yes, a $600M external investment round in March 2025, and a Series B in February 2026.

Does NExTNet allow sharing discoveries?

Yes, it supports collaboration via maps and lists.

What drug targets did Isomorphic Labs work on with J&J?

The collaboration (announced Jan 2026) focuses on AI-driven drug discovery, but specific targets are not disclosed.

Is NExTNet suitable for non-biomedical research?

No, it is focused on life sciences and may not cover other domains.

More NExTNet or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026